Expression and correlation of IL-35 in gingival crevicular fluid and serum with chronic periodontitis

Abstract

Abstract: PURPOSE: To investigate the concentration of IL-35 in serum and gingival crevicular fluid (GCF) and the correlation between IL-35 and periodontal clinical parameters, and explore the possible role of IL-35 in chronic periodontitis (CP). METHODS: Twenty patients with moderate or severe chronic periodontitis were selected as experimental group and 20 healthy people were included as control group. The patients’ baseline information, probing depth (PD) and clinical attachment level (CAL) were recorded. Their serum and GCF were collected and then the concentration of IL-35 in GCF and serum were detected by ELISA. SPSS19.0 software package was used for statistical analysis. RESULTS: The concentration of IL-35 in GCF and serum of chronic periodontitis were significantly higher than the control group (P<0.001). There was significant negative correlation between IL-35 and clinical parameters. CONCLUSIONS: Chronic periodontitis may increase the concentration of IL-35 in serum and GCF; IL-35 level is negatively correlated with periodontitis.

Key words: Interleukin 35, Serum, Gingival crevicular fluid, Chronic periodontitis, Systemic disease Shanghai J Stomatol, 2015, 24(4):455-459.

CLC Number:

R780.2

LIU Di-xin, JIN Ying, LIN Xiao-ping. Expression and correlation of IL-35 in gingival crevicular fluid and serum with chronic periodontitis[J]. Shanghai Journal of Stomatology, 2015, 24(4): 455-459.

References

[1] 靳赢, 王琳源, 林晓萍. 实验性牙周炎中调节性T细胞的检测及免疫状态 [J]. 上海口腔医学, 2013, 22(5): 487-491.
[2] 王琳源, 靳赢, 林晓萍. 适应性免疫应答在牙周炎发生中的作用 [J]. 中华口腔医学杂志, 2013, 48(2): 115-118.
[3] Wang L, Wang J, Jin Y, et al. Oral administration of all-trans retinoic acid suppresses experimental periodontitis by modulating the Th17/Treg imbalance[J]. J Periodontol, 2014, 84(5): 740-750.
[4] Hu Y, Dong C, Yue Y, et al. In vivo delivery of interleukin-35 relieves coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells [J]. Arch Virol, 2014, 159(9): 2411-2419.
[5] Terayama H, Yoshimoto T, Hirai S, et al. Contribution of IL-12/IL-35 common subunit p35 to maintaining the testicular immune privilege [J]. PLoS One, 2014, 9(4): e96120.
[6] Liu JQ, Liu Z, Zhang X, et al. Increase Th17 and regulatory T cell responses in EBV-induced gene3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis[J]. J Immunol, 2012, 188(7): 3099-3106.
[7] Tirotta E, Duncker P, Oak J, et al. Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis [J]. J Neuroimmunol, 2013, 254(1-2): 110-116.
[8] Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 + T cells regulates tissue inflammation by producing interleukin 17 [J]. Nat Immunol, 2005, 6(11): 1133-1141.
[9] 孟焕新. 牙周病学[M]. 第3版. 北京: 人民卫生出版社, 2008: 118-124,191.
[10] 吴赟, 陈凌, 魏斌, 等. 龈下及动脉粥样硬化斑块中牙周致病菌的同源性分析 [J]. 口腔医学研究, 2013, 29(6): 543-546.
[11] Zhou X, Han J, Liu Z, et al. Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: a 2-year pilot randomized controlled trial[J]. J Clin Periodontol,2014,41(6): 564-572.
[12] Hern&#x0dbc0;&#x0dd61;ndez M1, Dutzan N, García-Sesnich J, et al. Host-pathogen interactions in progressive chronic periodontitis[J]. J Dent Res, 2011, 90(10): 1164-1170.
[13] 王琳源, 靳赢, 林晓萍. CD4 + T细胞在不同菌株诱导小鼠牙周炎中的表达 [J]. 上海口腔医学, 2014, 23(1): 20-25.
[14] Huang Y, Lin YZ, Shi Y, et al. IL-35: a potential target for the treatment of atherosclerosis[J]. Pharmazie, 2013, 68(10): 793-795.
[15] Wang Y, Dong JB, Meng WY, et al. Effects of phased joint intervention on IL-35 and IL-17 expression levels in patients with portal hypertension [J]. Int J Mol Med, 2014, 33(5): 1131 -1139.
[16] Pope RM, Shahrara S. Possible roles of IL-12-family cytokines in rheumatoid arthritis [J]. Nat Rev Rheumatol, 2013, 9(4): 252-256.
[17] Kempe S, Heinz P, Kokai E, et al. Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques [J]. Am J Pathol, 2009, 175(1): 440-447.
[18] 台适, 周胜华, 刘启明, 等. 冠心病患者血浆白细胞介素35水平及临床意义的探讨[J]. 临床心血管病杂志, 2014, 30(1): 81-84.
[19] Kochetkova I, Golden S, Holderness K, et al. IL-35 stimulation of CD39 + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10 [J]. J Immunol, 2010, 184(12): 7144-7153.
[20] Wirtz S, Billmeier U, Mchedlidze T, et al. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis [J]. Gastroenterology, 2011, 141(5):1875-1886.
[21] Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases [J]. Nature, 2014, 507(7492): 366-370.
[22] Kalburgi NB, Muley A, Shivaprasad BM, et al. Expression profile of IL-35 mRNA in gingiva of chronic periodontitis and aggressive periodontitis patients: a semiquantitative RT-PCR study [J]. Dis Markers, 2013, 35(6): 819-823.
[23] Collison LW, Chaturvedi V, Henderson AL, et al. IL-35-mediated induction of a potent regulatory T cell population [J]. Nat Immunol, 2010, 11(12): 1093-1101.